Design, synthesis, biological evaluation, and docking study of 4‐isochromanone hybrids bearing N‐benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors (part II)
Moiety
Docking (animal)
IC50
DOI:
10.1111/cbdd.13136
Publication Date:
2017-11-07T17:32:34Z
AUTHORS (9)
ABSTRACT
A series of novel 4‐isochromanone compounds bearing N ‐benzyl pyridinium moiety were designed and synthesized as acetylcholinesterase ( AC hE) inhibitors. The biological evaluation showed that most the target exhibited potent inhibitory activities against hE. Among them, compound 1q possessed strongest anti‐ hE activity with an IC 50 value 0.15 n m high hE/BuChE selectivity SI > 5,000). Moreover, had low toxicity in normal nerve cells was relatively stable rat plasma. Together, current finding may provide a new approach for discovery anti‐Alzheimer's disease agents.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (17)
CITATIONS (18)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....